These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 29700638)
1. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors. Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638 [TBL] [Abstract][Full Text] [Related]
2. Frequency and risk factors of bleomycin-induced pulmonary toxicity in South Indian patients with germ-cell tumors. Thakkar DN; Ramasamy K; Adithan S; Selvarajan S; Dubashi B J Cancer Res Ther; 2021; 17(2):443-449. PubMed ID: 34121690 [TBL] [Abstract][Full Text] [Related]
3. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin. Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study. Kier MG; Lauritsen J; Mortensen MS; Bandak M; Andersen KK; Hansen MK; Agerbaek M; Holm NV; Dalton SO; Johansen C; Daugaard G Eur Urol; 2017 Feb; 71(2):290-298. PubMed ID: 27649970 [TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study. Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors. Maruyama Y; Sadahira T; Araki M; Mitsui Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y Int J Urol; 2019 Aug; 26(8):813-819. PubMed ID: 31115106 [TBL] [Abstract][Full Text] [Related]
9. Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center. Aurilio G; Verri E; Frassoni S; Bagnardi V; Cossu Rocca M; Cullurà D; Milani M; Mascia R; Curigliano G; Orsi F; Jereczek-Fossa BA; Musi G; Omodeo Salè E; De Cobelli O; Nolè F Am J Clin Oncol; 2020 Jun; 43(6):381-387. PubMed ID: 32079853 [TBL] [Abstract][Full Text] [Related]
10. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial. Grimison PS; Stockler MR; Thomson DB; Olver IN; Harvey VJ; Gebski VJ; Lewis CR; Levi JA; Boyer MJ; Gurney H; Craft P; Boland AL; Simes RJ; Toner GC J Natl Cancer Inst; 2010 Aug; 102(16):1253-62. PubMed ID: 20631341 [TBL] [Abstract][Full Text] [Related]
11. A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3). Shamash J; Sarker SJ; Huddart R; Harland S; Joffe JK; Mazhar D; Birtle A; White J; Chowdhury K; Wilson P; Marshall MR; Vinnicombe S Ann Oncol; 2017 Jun; 28(6):1333-1338. PubMed ID: 28327896 [TBL] [Abstract][Full Text] [Related]
12. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma. Sun HL; Atenafu EG; Tsang R; Kukreti V; Marras TK; Crump M; Kuruvilla J Leuk Lymphoma; 2017 Nov; 58(11):2607-2614. PubMed ID: 28504035 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157 [TBL] [Abstract][Full Text] [Related]
14. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. de Wit R; Roberts JT; Wilkinson PM; de Mulder PH; Mead GM; Fosså SD; Cook P; de Prijck L; Stenning S; Collette L J Clin Oncol; 2001 Mar; 19(6):1629-40. PubMed ID: 11250991 [TBL] [Abstract][Full Text] [Related]
15. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors]. Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774 [TBL] [Abstract][Full Text] [Related]
16. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors. Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937 [TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for metastatic germ cell tumours of the testis]. Culine S Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740 [TBL] [Abstract][Full Text] [Related]
19. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity. Kawai K; Hinotsu S; Tomobe M; Akaza H Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027 [TBL] [Abstract][Full Text] [Related]
20. Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers. den Hollander MW; Westerink ND; Lubberts S; Bongaerts AH; Wolf RF; Altena R; Nuver J; Oosting SF; de Vries EG; Walenkamp AM; Meijer C; Gietema JA Oncologist; 2016 Aug; 21(8):995-1001. PubMed ID: 27328932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]